Fox Corp. Cl A Stock Rises Wednesday, Still Underperforms Market

Spectrum Pharmaceuticals Inc

Change company Symbol lookup

Select an option...

SPPI Spectrum Pharmaceuticals Inc

FDBC Fidelity D&D Bancorp Inc

$BUKCHET Bloomberg Coffee Subindex Euro

BMY Bristol-Myers Squibb Co

MLGO MicroAlgo Inc

FRST Primis Financial Corp

VII 7GC & Holdings Co Inc

PEBO Peoples Bancorp Inc

BIOAF Bioasis Technologies Inc

NRGOF Newrange Gold Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value

Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

Fox Corp. Cl A Stock Rises Wednesday, Still Underperforms Market

4:55 pm ET November 23, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Fox Corp. Cl A (FOXA) inched 0.58% higher to $31.08 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.59% to 4,027.26 and the Dow Jones Industrial Average rising 0.28% to 34,194.06. This was the stock's second consecutive day of gains. Fox Corp. Cl A closed $13.87 short of its 52-week high ($44.95), which the company achieved on February 10th.

The stock underperformed when compared to some of its competitors Wednesday, as Walt Disney Co. (DIS) rose 2.78% to $98.88, Netflix Inc. (NFLX) rose 1.68% to $291.50, and Comcast Corp. Cl A (CMCSA) rose 1.23% to $35.53. Trading volume (2.4 M) remained 802,979 below its 50-day average volume of 3.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 23, 2022.

(END) Dow Jones Newswires

November 23, 2022 16:55 ET (21:55 GMT)